Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 1 Endometrial Cancer”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Very early researchNot Yet RecruitingNCT07812636
What this trial is testing

Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer

Who this might be right for
Grade 1 Endometrial Endometrioid CarcinomaEndometrial Intraepithelial NeoplasiaMetabolic Comorbidities
Milton S. Hershey Medical Center 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05538897
What this trial is testing

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Who this might be right for
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaMetastatic Endometrial Endometrioid Adenocarcinoma+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT04293094
What this trial is testing

Study of AMG 650 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Volastra Therapeutics, Inc. 66
Not applicableLooking for participantsNCT04008563
What this trial is testing

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium

Who this might be right for
Endometrial CancerAtypical HyperplasiaBariatric Surgery Candidate
University Health Network, Toronto 36
Large-scale testing (Phase 3)Study completedNCT00002706
What this trial is testing

Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus

Who this might be right for
Endometrial AdenocarcinomaStage I Uterine Corpus CancerStage I Uterine Sarcoma+2 more
Gynecologic Oncology Group 2,616
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Very early researchStudy completedNCT03018249
What this trial is testing

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Who this might be right for
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaFIGO Grade 3 Endometrial Endometrioid Adenocarcinoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT05903131
What this trial is testing

Uterine Preservation Via Lifestyle Transformation

Who this might be right for
Endometrial HyperplasiaGrade 1 Endometrial Cancer
Washington University School of Medicine 96
Early research (Phase 1)Ended earlyNCT05229900
What this trial is testing

SGN-ALPV in Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung+4 more
Seagen Inc. 43
Testing effectiveness (Phase 2)Study completedNCT05634499
What this trial is testing

Giredestrant in Participants With Grade 1 Endometrial Cancer

Who this might be right for
Endometrial Cancer
Hoffmann-La Roche 33
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06073184
What this trial is testing

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium

Who this might be right for
Endometrial CancerAtypical Hyperplasia
University Health Network, Toronto 71
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT00788671
What this trial is testing

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaStage I Uterine Corpus Cancer AJCC v7Stage IA Uterine Corpus Cancer AJCC v7+2 more
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT02397083
What this trial is testing

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
M.D. Anderson Cancer Center 102
Testing effectiveness (Phase 2)Looking for participantsNCT03564340
What this trial is testing

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Who this might be right for
Recurrent Ovarian CancerRecurrent Fallopian Tube CancerRecurrent Primary Peritoneal Cancer+3 more
Regeneron Pharmaceuticals 890
Testing effectiveness (Phase 2)UnknownNCT00003135
What this trial is testing

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+1 more
The University of Texas Health Science Center, Houston 34
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Next Page
96